The inverse correlation between A20 and DREAM observed in our study suggests a regulatory feedback loop, highlighting the therapeutic potential of simultaneously modulating both molecules in SSc and other fibrotic diseases. This evidence concerns the gene KCNIP3 and systemic sclerosis.